Table 1 Patient characteristics

From: Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study

Total

24

Males

15

Females

9

Median age (range)

62.6 years (45–79)

Zubrod performance status

 0

3 (12%)

 1

12 (50%)

 2

9 (38%)

TNM stage

 II

1 (4%)

 IIIa

1 (4%)

 IIIb

10 (42%)

 IV

12 (50%)

Histology

 Squamous

14 (58%)

 Adenocarcinoma

6 (25%)

 Undifferentiated

4 (17%)

Back to article page